Results 91 to 100 of about 13,355 (171)

Exploring nurses' experiences of a tailored intervention to increase MMR vaccine acceptance in a Somali community in Stockholm, Sweden: a qualitative interview study. [PDF]

BMJ Open, 2023
Appelqvist E, Jama A, Kulane A, Roth A, Lindstrand A, Godoy-Ramirez K.   +5 more
europepmc   +1 more source

MMR vaccine coverage and associated factors among overseas-born refugee children resettled in Aotearoa New Zealand: a national retrospective cohort study. [PDF]

Lancet Reg Health West Pac, 2023
Charania NA, Paynter J, Turner N.
europepmc   +1 more source

Parents' and Health Professionals' Attitudes to Advancing Primary MMR Vaccine Administration from Fifteen to Six Months of Age-A Qualitative Thematic Analysis Embedded in a Randomized Trial. [PDF]

Vaccines (Basel), 2022
Kirkedal AK, Møller JE, Stensballe LG, Zoffmann V.   +3 more
europepmc   +1 more source

Surveillance and analysis of adverse events following immunization (AEFI) with measles, mumps, and rubella (MMR) vaccine in Zhejiang Province, China, 2020-2025. [PDF]

Front Public Health
Pan X, Chen Y, He H, Qi X, Shen L, Liang H.   +5 more
europepmc   +1 more source

Response to Measles, Mumps and Rubella (MMR) Vaccine in Transfusion-Dependent Patients. [PDF]

Vaccines (Basel), 2021
Casale M, Di Maio N, Verde V, Scianguetta S, Di Girolamo MG, Tomeo R, Roberti D, Misso S, Perrotta S.   +8 more
europepmc   +1 more source

Comparative Efficacy and Safety of Intralesional MMR Vaccine and Vitamin D3 in Managing Nongenital Warts: A Systematic Review and Meta-Analysis. [PDF]

J Cosmet Dermatol
Balach R, Khalid A, Rasool A, Kashif A, Ahmad A, Zafar A, Ibrahim M, Javed AS, Hasan M, Ahmed S.   +9 more
europepmc   +1 more source

Complete Regression of Anogenital Warts Following Intralesional Measles-Mumps-Rubella (MMR) Vaccine: A Case of Two. [PDF]

Clin Cosmet Investig Dermatol
Achdiat PA, Dwigunasari PR, Suwarsa O, Tsaqilah L, Maharani RH.   +4 more
europepmc   +1 more source

A Randomized Comparative Study of MIP and MMR Vaccine for the Treatment of Cutaneous Warts. [PDF]

Indian J Dermatol, 2021
Kaur A, Brar BK, Kumar S, Brar SK, Boparai AS, Puri N.   +5 more
europepmc   +1 more source

Correction to: 571. A Report of the Postmarketing Spontaneous Safety Data over 24 Years for GSK's Measles-Mumps-Rubella (MMR) Vaccine. [PDF]

Open Forum Infect Dis, 2023
europepmc   +1 more source

Gene Expression Factors Associated with Rubella-Specific Humoral Immunity After a Third MMR Vaccine Dose. [PDF]

Viruses
Teodoro LI, Haralambieva IH, Ovsyannikova IG, Goergen KM, Grill DE, Poland GA, Kennedy RB.   +6 more
europepmc   +1 more source